论文信息 - Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009–2016 - 字舞流文

Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009–2016

P. Groeneveld | Ashwin S. Nathan | D. Kolansky | S. Tuteja | E. Dayoub | S. A. Khatana | M. Seigerman | Taisei J Kobayashi | Jay Giri

[1] J. Iqbal,et al. Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease , 2018, Circulation.

[2] P. Groeneveld,et al. Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016 , 2018, JAMA internal medicine.

[3] J. Cigarroa,et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, The Journal of thoracic and cardiovascular surgery.

[4] G. Montalescot,et al. Potent P2Y12 Inhibitors in Low-Risk Patients: Is There a Medical Need? , 2016, Journal of the American College of Cardiology.